According to Varma, African Americans have a high rate of visual impairment and are especially likely to develop open-angle ...

Letter writers discuss Improving Seniors’ Timely Access to Care Act, attacks against President Trump, and five tenets of ...

Annexon has completed enrollment in its phase 3 ARCHER II trial of vonaprument (formerly ANX007) for dry age-related macular ...

The trial subjects were adults with either type 1 or type 2 diabetes, exhibiting central involvement in diabetic macular ...

Doctors in India are constantly raising alarms over the rise in cases of vision loss among those battling type 2 ...

Microaneurysm (MA) turnover increases with the progression of nonproliferative diabetic retinopathy (NPDR) and is correlated with presence of intraretinal microvascular abnormalities (IRMAs), ...

An AI model integrated into a retina tracker for diabetic retinopathy can achieve high accuracy while being resource-efficient.

Diabetic retinopathy is a common complication of diabetes, which manifests as a potentially severe eye disease that can lead ...

Danegaptide, a potential oral therapy for nonproliferative diabetic retinopathy, is advancing to a phase 2 trial after ...

Joint Venture Partner Presents AI Technology at Roche Ophthalmology Conference - Avant Technologies, Inc. ("Avant" or the "Company"), an emerging technology company developing healthcare solutions ...

Ophthalmology Times connects eye care professionals with surgery, imaging, gene therapy, & diagnostic advances to enhance ...

It is projected that the global Ophthalmic Lasers Market will be valued at USD 976.8 million in 2024 and USD 1,561.0 million in 2034. During the projection period from 2024 to 2034, sales are expected ...